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Abstract
Age-related hearing loss – presbycusis – is the number one neurodegenerative disorder and top communication deficit of
our aged population. Like many aging disorders of the nervous system, damage from free radicals linked to production of
reactive oxygen and/or nitrogen species (ROS and RNS, respectively) may play key roles in disease progression. The efficacy
of the antioxidant systems, e.g., glutathione and thioredoxin, is an important factor in pathophysiology of the aging nervous
system. In this investigation, relations between the expression of antioxidant-related genes in the auditory portion of the
inner ear – cochlea, and age-related hearing loss was explored for CBA/CaJ mice. Forty mice were classified into four groups
according to age and degree of hearing loss. Cochlear mRNA samples were collected and cDNA generated. Using
AffymetrixH GeneChip, the expressions of 56 antioxidant-related gene probes were analyzed to estimate the differences in
gene expression between the four subject groups. The expression of Glutathione peroxidase 6, Gpx6; Thioredoxin reductase
1, Txnrd1; Isocitrate dehydrogenase 1, Idh1; and Heat shock protein 1, Hspb1; were significantly different, or showed large
fold-change differences between subject groups. The Gpx6, Txnrd1 and Hspb1 gene expression changes were validated
using qPCR. The Gpx6 gene was upregulated while the Txnrd1 gene was downregulated with age/hearing loss. The Hspb1
gene was found to be downregulated in middle-aged animals as well as those with mild presbycusis, whereas it was
upregulated in those with severe presbycusis. These results facilitate development of future interventions to predict,
prevent or slow down the progression of presbycusis.
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Introduction
Oxidative stress has a definite role in cell aging. The
multifactorial approach of explaining the processes of aging in
the ear and brain results in different theories. Some of these
theories explain aging as an evolutionary effect (e.g. mutation
accumulation theory, particularly for the mitochondrial genome),
others explain it as a molecular effect (e.g., gene regulation theory),
a cellular effect (e.g., telomere length theory), or a systemic effect
(e.g., neuroendocrine and immunological theories).
One of the main cellular theories of aging is the free radical
theory. According to this, aging is the result of accumulative effects
of oxidative insults throughout the life span [1] caused by reactive
oxygen and/or nitrogen species (ROS and RNS, respectively) [2–
5]. The main source of ROS in the cell is the mitochondrial
leakage of electrons, followed by production of superoxides, and
hydrogen peroxide (H2O2) [6–7]. The lack of ability to scavenge
all of these oxidants from the cell leads to DNA, lipids and protein
damage [8–11]. Lipid damage, in turn, can lead to calcium (Ca++)
influx and pathological changes in the cells [12–13]. DNA damage
can be more permanent, cumulative and have more devastating
consequences than lipid or protein damage. The fact that
mitochondria continue to replicate, and that the mitochondrial
genome almost entirely codes for proteins, makes mitochondrial
DNA (mtDNA) oxidative damage very important and potentially
dangerous to cellular health, even relative to nuclear DNA
damage [1,14–15].
Thiol-reducing systems, glutathione (GSH) and thioredoxin
(Trx) are two major cellular antioxidant systems that play an
important role in maintaining the proper intracellular redox
concentration. Other redox compounds, such as nicotinamide
adenine dinucleotides (NADPH, NADH), ascorbic acid (Vitamin
C), tocopherols (Vitamin E), lipoic acid, and ubiquinone (Q10), in
addition to antioxidant enzymes like dimutate superoxide (SOD-1
and SOD-2), catalases and peroxidases also play roles in cell
protection [16]. The balance between these systems and ROS/
RNS production is vital for cell survival. Decreases in levels of
antioxidants along with overwhelming exposure to oxidative stress
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can accelerate the process of cellular age-related damage [17–19].
Due to its high intracellular concentration, GSH is thought to be
largely responsible for antioxidant protective effects inside cells
and organelles. In addition to its action as a major antioxidant
defense, Trx may play an important role in the redox regulation of
protein thiols involved in signal transduction, gene regulation and
cell growth [16,20–21].
Age-related hearing loss is the number one neurodegenerative
disorder and top communication deficit of our growing aged
population; and along with arthritis and cardiovascular disease,
one of the top three chronic medical conditions of the elderly. The
CBA mouse strain has been one of the most useful in terms of
understanding the behavioral, neural and molecular bases of age-
related hearing loss at both sensory end-organ (inner ear: cochlear)
and brain (central auditory system) levels [22–25]. In the present
study, age- and function-related changes in antioxidant-related
cochlear gene expression in different age groups of CBA mice were
investigated. Utilizing gene microarrays, candidate genes that may
participate in presbycusis – age-related hearing loss - at the
cochlear level were identified.
Methods
The present investigation utilized methodologies similar to
Tadros, Frisina and colleagues [26–28].
Animal Model
CBA/CaJ mice were bred in-house and housed according to
institutional protocol, with original breeding pairs obtained from
Jackson Laboratories. All animals had similar environmental and
non-ototoxic history. The CBA mouse is a model organism for
human presbycusis because it loses its hearing progressively over
its lifespan. The young adult group was used as the baseline group
for gene expression data analyses (e.g., calculation of fold changes).
Functional hearing measurements were obtained prior to sacrifice
similar to our previous investigations of the biological bases of
presbycusis [29–31]. Before data acquisition, individual mice were
microscopically examined for evidence of external ear canal and
middle ear obstruction. Mice with clearly visualized, healthy
tympanic membranes were included. This study was carried out in
strict accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes of
Health, and all procedures were fully approved by the University
of Rochester Vivarium Committee on Animal Resources.
Functional Hearing Assessment
Distortion Product Otoacoustic Emissions (DPOAEs).
Ipsilateral acoustic stimulation and simultaneous measurement of
DPOAEs were accomplished with the Tucker Davis Tech. (TDT)
BioSig III system. Stimuli were digitally synthesized at 200 kHz
using SigGen software applications with the ratio of frequency 2
(F2) to frequency 1 (F1) constant at 1.25; L1 was equal to 65 dB
sound pressure level (SPL) and L2 was equal to 50 dB SPL as
calibrated in a 0.1-mL coupler simulating the mouse ear canal.
After synthesis, F1, F2, were each passed through an RP2.1 D/A
converter to PA5 programmable attenuators. Following attenua-
tion, the signals went to ED1 speaker drivers which fed into the
EC1 electrostatic loudspeakers coupled to the ear canal through
short, flexible tubes with rigid plastic tapering tips. For DPOAE
measurements, resultant ear canal sound pressure was recorded
with an ER10B+ low-noise microphone and probe (Etymotic)
housed in the same coupler as the F1 and F2 speakers. The output
of the ER10B+ amplifier was put into an MA3 microphone
amplifier, whose output went to an RP2.1 A/D converter for
sampling at 200 kHz. A fast Fourier transform (FFT) was
performed with TDT BioSig software on the resultant waveform.
The magnitude of F1, F2, the 2f1-f2 distortion product, and the
noise floor of the frequency bins surrounding the 2f1-f2
components were measured from the FFT. The procedure was
repeated for geometric mean frequencies ranging from 5.6 to
44.8 kHz (eight frequencies per octave) to adequately assess the
neuroethologically functional range of mouse hearing.
Mice were anesthetized with a mixture of ketamine and xylazine
(120 and 10 mg/kg body weight, respectively) by intraperitoneal
injection before all experimental sessions. All recording sessions
were completed in a soundproof acoustic chamber (lined with
Sonex) with body temperature maintained with a heating pad.
Before recording, the operating microscope (Zeiss) was used to
place the stimulus probe and microphone in the test ear, and the
coupler for the speaker for the contralateral noise source was
placed into the opposite ear canal. Both couplers were placed close
to the tympanic membrane. The recording session duration was
limited by depth of anesthesia, and lasted approximately 1 hour
per animal.
Auditory Brainstem Responses (ABRs). During this pro-
cedure, 5.0 mg/10.0 gm body weight general anesthetic, Avertin
(Tribromoethanol, delivered IP), was used to anaesthetize the
mice. Normal body temperature was maintained at 38uC with a
Servo heating pad. Auditory brainstem responses were measured
in response to tone pips of 3, 6, 12, 24, 32, and 48 kHz presented
at a rate of 11 bursts/sec. Auditory brainstem responses were
recorded with subcutaneous platinum needle electrodes placed at
the vertex (noninverting input), right-side mastoid prominence
(inverted input), and tail (indifferent site). Electroencephalographic
(EEG) activity was differentially amplified (50 or 100 X) (Grass
Model P511 EEG amplifier), then put into an analogue-to-digital
converter (AD1, TDT) and digitized at 50 kHz. Each averaged
response was based on 300–500 stimulus repetitions recorded over
10-millisec epochs. Contamination by muscle and cardiac
activities was prevented by rejecting data epochs in which the
Table 1. ANOVA results of genechip signal log ratios between groups and average fold changes of validated genes.
Gene ID Gene Name ANOVA (Sig. Log. Ratio) GeneChip Average Fold Change
Middle Age Old Mild Old Severe
1425964_x_at Hspb1 P= 0.0598, F = 3.11, df = 2,29 20.7729 21.245 0.5188
1452135_at Gpx6 P = 0.0681, F = 2.95, df = 2,29 0.9848 1.550 1.310
1421529_a_at Txnrd1 P = *0.0219, F = 4.37, df = 2,29 20.1404 21.138 21.485
1419821_s_at Idh1 (NADP+) P = *0.0131, F = 5.05, df = 2,29 20.2129 21.032 21.612
* denotes statistical significance at 0.05 level.
doi:10.1371/journal.pone.0090279.t001
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single-trace electroencephalogram contained peak-to-peak ampli-
tudes exceeding 50 mV. The ABR was recorded in a small sound-
attenuating chamber.
Sample Isolation
Upon completion of the physiological recording sessions, the
mice were sacrificed by cervical dislocation. The brains were
immediately dissected using a Zeiss stereomicroscope and placed
in ice-cold saline. The soft tissues of forty CBA mice cochleae were
dissected. The two cochleae of each mouse were pooled together
to form one sample per mouse. All samples were placed in cold
Trizol (Invitrogen, CA) and stored at 280uC for gene microarray
and real time PCR processing.
Microarray gene expression processing
Gene Chip. One Affymetrix M430A high-density oligonu-
cleotide array set (A) (Affymetrix Inc., Santa Clara, CA) was used
for each cochlea sample. Each array contains 22,600 probe sets
analyzing the expression of over 14,000 mouse genes. Eleven pairs
of 25-mer oligonucleotides that span the coding region of the genes
represent each gene. Each probe pair consists of a perfect match
sequence that is complementary to the mRNA target and a
mismatch sequence that has a single base pair mutation in a region
critical for target hybridization; this sequence serves as a control
for non-specific hybridization. Sequences used in the design of the
array were selected from GenBank, dbEST, and RefSeq.
Sample Preparation
RNA Extraction. These procedures are described in detail in
our previous microarray articles [26–28].
cDNA Synthesis. For gene array analysis, cDNA synthesis
was performed with 20 mg of total RNA using the Superscript
Choice cDNA Synthesis Kit (Invitrogen). For qPCR, nuGen
cDNA reagents kit was used to generate a high fidelity cDNA,
which was modified at the 39 end to contain an initiation site for
T7 RNA polymerase. Detailed protocol is found in www.
nugeninc.com.
In-vitro Transcription (IVT) and Fragmentation. Clean
up of double-stranded cDNA was done according to the
Affymetrix GeneChip Expression analysis protocol. Synthesis of
Biotin-labeled cRNA was performed by adding 1 mg of cDNA to
10X IVT labeling buffer, IVT labeling NTP mix, IVT labeling
enzyme mix and RNase-free water, then incubated at 37uC for
16 hours. The Biotin-labeled cRNA was cleaned up according to
the Affymetrix GeneChip expression analysis protocol and a 20 mg
of full-length cRNA from each sample was fragmented by adding
5X fragmentation buffer and RNase-free water, followed by
incubation at 94uC for 35 min. The standard fragmentation
procedure produces a distribution of RNA fragment sizes from
approximately 35 to 200 bases. After the fragmentation, cDNA,
full-length cRNA and fragmented cRNA were analyzed by
electrophoresis using the Agilent Bioanalyzer 2100 to assess the
appropriate size distribution prior to microarray hybridization.
Target Hybridization, Washing, Staining and
Scanning. GeneChip M430A probe arrays (Affymetrix) were
hybridized, washed and stained according to the manufacturer’s
instructions in a fluidics station. The arrays were scanned using a
Hewlett Packard confocal laser scanner and visualized using
GeneChip 5.1 software. Three data files were created, namely
image data (.dat), cell intensity data (.cel) and expression probe
analysis data (.chp) files. Detailed protocols for sample preparation
and target labeling assays for expression analysis can be found at
http://www.Affymetrix.com.
Figure 1. A): For both GeneChip and real-time PCR, fold
changes of Hspb1 gene expression in the cochleae of middle
age, old mild hearing loss, and old severe hearing loss groups
showed upregulation with age and hearing loss. B): For both
GeneChip and real-time PCR, fold changes of Gpx6 gene expression in
cochlea samples showed upregulation in all age groups compared to
the young group. C): For both GeneChip and real-time PCR, fold
changes of Txnrd1 gene expression in the cochleae of middle age, old
mild hearing loss, and old severe hearing loss groups showed
downregulation with age and hearing loss.
doi:10.1371/journal.pone.0090279.g001
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GeneChip Data Access
The entire microarray probe-set from each GeneChip 430A
and individual CBA mouse phenotypic (hearing measures) data
have been submitted to the GEO-NCBI database, and have been
approved with the following Series reference #: GSE GSE49543.
These GeneChip data can be accessed via, http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc =GSE49543. The probe-sets used
in the current article were derived from the above GEO-NCBI
accession number GSE49543. All steps were conducted according
to the MIAME (Minimum Information About a Microarray
Experiment) checklist [61].
Real-time PCR (qPCR)
The primer/probe used in quantification of gene expression was
acquired from TaqManH Gene Expression Assays-on-Demand
products (AOD) from Applied Biosystems, Inc. (Foster City, CA,
USA).
Detailed information about the PCR protocols is found in www.
appliedbiosystems.com, and in our previous microarray articles
[26–28].
Statistical Analyses
GeneChip Expression Analysis. After assessing chip qual-
ity, the Affymetrix GeneChip Operating Software (GCOS)
automatically generates the (.cel) image file from the (.dat) data
file. The signal log ratio of each sample determined the difference
in expression of the studied gene in that sample from the mean
expression of that gene in all samples from the young adult mice. A
signal log ratio of 1.0 indicates an increase of the transcript level by
2 fold and 21.0 indicates a decrease by 2 fold. A signal log ratio of
zero indicates no change.
For the fifty-six antioxidant-related genechip probes, one-way
Analysis of Variance (ANOVA) (95% confidence limit) was used to
compare between the signal log ratio values of the different subject
groups. In addition, fold changes of all samples were calculated
from signal log ratios using the following equations:
Fold Change~2signal log ratioif signal log ratio§0 or
({1)x2({SignalLogRatio)if signal log ratiov0
Real Time PCR Analysis
The threshold cycle (CT ) values were measured to detect the
threshold of each of four significant genes of interest and GAPDH
gene in all samples [32–33]. Each sample was measured in
triplicate and normalized to the reference GAPDH gene expres-
sion. The CT value of each well was determined and the average
of the three wells of each sample was calculated. For samples that
showed no expression of the test gene, the value of minimum
expression was used for statistical analysis.
Delta CT (DCT ) for test gene of each sample was calculated
using the equation:
DCT~CT Test GeneT GAPDH
Figure 2. ABR thresholds correlation with gene expression A) and B): The correlations between Gxp6 qPCR fold changes and ABR
thresholds at 12 kHz and 48 kHz are two examples of the significant correlations of gene expression changes with ABR test results.
C) and D): The correlations between Txnrd1 signal log ratio and ABR thresholds at 12 kHz and 48 kHz were significant.
doi:10.1371/journal.pone.0090279.g002
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Delta delta CT (DDCT ) was calculated using the following
equation:
DDCT~DCT Sample AverageDCT young group
The fold change in the test gene expression was finally
calculated from the formula:
Fold change 2 {DDCTð Þ if DDCTƒ0 or {1ð Þ
.
2 {DDCTð Þif DDCw0
A statistical evaluation of real time PCR results was performed
using one-way ANOVA to compare between DCT for test gene
expression in young age, middle age, old age mild presbycusis, and
old age severe presbycusis groups.
For the three significantly different genes on genechip and/or
qPCR, linear regression analyses were employed to find correla-
tions between the signal log ratio values or fold change and the
functional hearing measurements. These measurements were the
distortion product otoacoustic emission (DPOAE) amplitudes at
low frequencies (5.6 kHz to 14.5 kHz), mid frequencies (15.8 kHz
to 29.0 kHz) and high frequencies (31.6 kHz to 44.8 kHz), in
addition to auditory brainstem response thresholds (ABR) at 3, 6,
12, 24, 32 and 48 kHz. The GraphPad Prism 4 software was used
to perform the one-way ANOVA and the linear regression
statistics.
Results
Subject Groups: Age and Hearing Functionality
The sample set segregated into 4 groups based upon age,
DPOAE levels and ABR thresholds: young adult control with
good hearing (N= 8, 4 males, 4 females, age = 3.5+/20.4 mon),
middle-aged with good hearing (N= 17, 8 males, 9 females,
age = 12.3+/21.3 mon), old with mild presbycusis (N= 9, 4 males,
5 females, age = 27.7+/23.4 mon) and old with severe presbycusis
(N= 6, 2 males, 4 females, age = 30.6+/21.9 mon). Detailed
audiological data were presented in Tadros et al. [26–27].
Microarray gene expression
Fifty-six antioxidant-related gene probes were present on the
microarray, and these were selected for further analysis. Statistical
computations comparing the signal log ratios (Table 1) and fold
changes of middle age, old mild hearing loss, and old severe hearing
loss subject groups showed significant differences in expression or
large fold-changes for four genes: Gpx6, Txnrd1, Idh1, and Hspb1.
These gene expression changes were selected for validation by
using real-time PCR (qPCR). In our selection of the genes to
validate with real-time PCR, we relied on either a significant
statistical difference of gene expression between groups (e.g., in the
case of Txnrd1 and Idh1) or a large numerical difference in the
microarray average fold change of the young adult group
compared to the middle and old groups (e.g., in the case of
Hspb1 and Gpx6). For Hspb1 and Gpx6, although the signal log
ratio differences were not statistically significant, notice that there
is a strong trend for gene expression group differences.
Figure 3. DPOAE amplitudes correlation with gene expression A) and B): The correlations between Gxp6 signal log ratio and DPOAE
amplitudes at mid and high frequencies, are two examples of the significant correlations of gene expression changes with DPOAE
test results. C) and D): The correlations between Txnrd1 signal log ratio and DPOAE amplitudes at low and mid frequencies were significant.
doi:10.1371/journal.pone.0090279.g003
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Real-time PCR (qPCR)
Three genes out of the four validated microarray genes showed
comparable results for both the genechip and the qPCR. These
three genes were: Hspb1 (p = *0.0345, F= 3.79, df = 2,29) and
Gpx6 (p = **0.0011, F= 8.644, df = 2,29) that showed significant
up-regulation and Txnrd1 (p = 0.6575, F= 0.4254, df = 2,29) that
showed down-regulation with age and hearing loss. For Idh1 gene,
the qPCR results did not show consistency with the genechip data.
Figures 1A–1C show quantitative comparisons between fold
changes for the genechip microarray expression changes and
those for the qPCR.
Correlation between gene expression and hearing
measurements
Linear regression tests were used to analyze the correlations
between hearing measurements (ABR thresholds and DPOAE
amplitudes) and gene expression for both the genechip and qPCR
expression levels. For Gpx6 expression upregulation, genechip and
q-PCR data showed significant correlations with both ABR
thresholds and DPOAE amplitudes (Table 2) (Figs. 2A–B, 3A–
B). For Txnrd1 gene expression down-regulation, genechip signal
log ratios and fold changes showed statistically significant
correlations with ABR thresholds and DPOAE amplitudes
(Table 3) (Fig. 2C–D, 3C–D). No significant correlations were
found between Hspb1 gene expressions as measured by qPCR and
audiological tests. This may be, because the qPCR method is
overall more sensitive than the genechip, for individual gene
analyses. When the qPCR results are used to calculate fold
changes, the results can have more variability than the genechip
fold changes, sometimes reducing the statistical power of the
correlations.
Discussion
Antioxidant Systems
The antioxidant systems, thiol-reducing Glutathione (GSH) and
thioredoxin (Trx), are the main cellular defense mechanisms
against free radicals. Catalyzed by the glutathione and thioredoxin
peroxidases, GSH and Trx can scavenge free radicals and reduce
peroxides producing glutathione disulfide (GSSG) and thioredoxin
disulfide, respectively. This oxidized form of glutathione and
thioredoxine can be converted back to the reduced form by
glutathione and thioredoxine reductases in a reaction requiring
NADPH. Since glutathione is the most abundant intracellular
redox, in addition to its major role as an antioxidant, the GSH/
GSSG ratio is considered as an indicator of the cellular redox
environment and has a major influence on cell proliferation and
differentiation [20,34]. Thioredoxin system has an equally
important role as an antioxidant and redox regulating system. In
addition it plays a key role in DNA synthesis and activation of
transcription factors that regulate cell growth [21]. In cases of
oxidative stress, these two antioxidant systems act, both in parallel
and interactive ways, to reduce ROS/RNS concentration and
regulate redox cellular environment [17,35].
Glutathione peroxidase (Gpx) isoforms are a family of enzymes
that slightly vary in properties [36]. The classic intracellular Gpx1
is expressed in varies types of tissues and Gpx3 is found intensively
in plasma, kidney, adrenal gland, and weakly in heart, lung and
cerebellum [37–38]. Gpx6 has been identified based on its close
homology with Gpx3 [39] and expressed in embryos and adult
olfactory epithelium. The expression of Gpx isoforms differs
depending on tissue type.
Thioredoxin reductase (Txnrd) is a selenoprotein. It has three
isoforms Txnrd1 (cytosolic), Txnrd2 (mitochondrial) and Txnrd3
(TGR or thioredoxin and glutathione reductase) [40–45]. The
inhibition of thioredoxine reductase enzyme may have a
devastating effect on the cell due to the inhibition of the whole
thioredoxin system [46]. In addition to its antioxidant effect, it has
been reported that Txnrd1 plays an important role in the control of
basal p53 activity [47].
Heat shock proteins (Hsps) are a multi-functional family of
proteins. Under stressful conditions, as infection, inflammation,
exposure to toxins, elevated temperature or other stress conditions,
Hsps have a cytoprotective function through working as a
molecular chaperon to repair or remove denatured proteins and
inhibit apoptosis [48–49].
Antioxidants and Cochlea
Different tissues in the cochlea may respond differently to the
damaging ROS but the effects of oxidative stress and antioxidant
systems on aging cochlea are well known [50–52]. Some reports
showed a significant lower activity of glutathione-related antiox-
idant enzymes with noise exposure and drugs [53–55]. Mutation
of the gene of Gpx1 was reported to increase the vulnerability to
noise-induced and age-related hearing loss in mice [56]. Ebselen, a
Gpx mimic seleno-organic compound, was found to have a
protective effect on cochlea against acoustic trauma, gentamicin
and cisplatin [57–58]. Though the role of thioredoxin system in
Table 2. Correlation between Gpx6 gene expression and audiological measurements.
Sig. Log Ratio (GeneChip) Fold Change (GeneChip) Fold Change (qPCR)
ABR 3 kHz p= 0.187, r2 = 0.045, F = 1.803 p= 0.239, r2 = 0.0362, F = 1.426 p= 0.186, r2 = 0.046, F = 1.815
ABR 6 kHz p= 0.065, r2 = 0.087, F = 3.618 p= 0.113, r2 = 0.0648, F = 2.632 p= 0.075, r2 = 0.081, F = 3.352
ABR 12 kHz p= *0.019, r2 = 0.137, F = 6.028 p= *0.047, r2 = 0.100, F = 4.237 p= *0.029, r2 = 0.119, F = 5.170
ABR 24 kHz p= *0.014, r2 = 0.149, F = 6.658 p= 0.051, r2 = 0.0963, F = 4.050 p= *0.048, r2 = 0.0989, F = 4.175
ABR 32 kHz p= *0.019, r2 = 0.136, F = 5.984 p= 0.052, r2 = 0.0959, F = 4.031 p= *0.022, r2 = 0.130, F = 5.699
ABR 48 kHz p= **0.002, r2 = 0.222, F = 10.84 p = *0.011, r2 = 0.159, F = 7.186 p= **0.004, r2 = 0.204, F = 9.721
DPOAE Low Freq. p= 0.117, r2 = 0.0634, F = 2.572 p= 0.269, r2 = 0.0319, F = 1.255 p= 0.579, r2 = 0.008, F = 0.312
DPOAE Mid Freq. p= *0.037, r2 = 0.109, F = 4.652 p= 0.159, r2 = 0.0515, F = 2.064 p= 0.237, r2 = 0.037, F = 1.44
DPOAE High Freq. p= *0.027, r2 = 0.123, F = 5.305 p= 0.119, r2 = 0.0625, F = 2.535 p= 0.217, r2 = 0.039, F = 1.576
* denotes statistical significance at 0.05 level;
** at the 0.01 level.
doi:10.1371/journal.pone.0090279.t002
Antioxidant Gene Changes in the Aging Cochlea
PLOS ONE | www.plosone.org 6 February 2014 | Volume 9 | Issue 2 | e90279
the central nervous system has been established [16], its protective
effect in the cochlea is still needed to be explored. It was reported
that Txnrd activation in strial melanocytes by low level acoustic
stimulation (LLAS) might be the cause of reduced susceptibility to
temporary noise-induced threshold shift [59]. Hsps are divided into
families according to their molecular weight. Heat shock protein
b1 (Hspb1), also called Hsp27, has been found in the outer hair
cells of rat cochlea and may provide a protection to these cells
against auditory trauma or oxidative stress. In addition, the
presence of high levels of Hsp27 in the cuticular plate and lateral
wall of outer hair cells may help the regulation of the actin
cytoskeleton against mechanical strain [60]. A limitation of the
present study is that we cannot be sure about the importance of
the up-regulation of Hspb1 expression in old age with severe
hearing loss. It could be explained as an attempt to protect the
cochlear hair cells from age-linked acoustic trauma and stress,
which requires further investigation.
In the present investigation, Txnrd1 was found to be downreg-
ulated while both Gpx6 and Hspb1 were upregulated in the CBA
mouse cochlea with age and hearing loss. These findings may be
explained as an exhaustion of the thioredoxin system with
oxidative stress, and a compensatory mechanism by both the
glutathione system and heat shock proteins in cochlear cells to
scavenge the excess free radicals. Hspb1 changes showed upregula-
tion only in the old severe hearing loss group that may indicate its
main relation with hearing loss. Though further studies may be
needed to provide the functional and histological proof of the
protective effect of antioxidants on age related hearing loss, the
strong correlations between both Txnrd1 or Gpx6 expression on
one hand and ABR thresholds and DPOAE amplitudes on the
other hand, point to direct relations of the expression of these
genes in the cochlea with age and hearing loss. The downregu-
lation of Txnrd1 expression may have a special therapeutic
significance for future efforts at prevention and/or treatment of
presbycusis through gene therapy techniques.
Recently, Tanaka et al. [62] studied the expression pattern of 84
oxidative stress and antioxidant defense-related genes in F344/
NHsd male albino rates, dividing their subject groups solely
according to age. In the present study, we used CBA/CaJ mice,
both males and females, to study 56 oxidative stress-related genes
and divided the animals into four groups according to two criteria,
both their age and audiological test (ABR and DPOAEs) results.
This categorization helped us to more clearly differentiate between
the effects of age and degree of hearing loss in the old age groups,
on the oxidative stress gene expression. Tanaka and colleagues
reported a statistically significant difference in expression between
age groups in thirteen genes (one was down-regulated and twelve
were up-regulated with age). Five genes were glutathione- and
thioredoxin-related (Gpx6, Gpx3, Gstk1, Txnip, and Gsr). The
expression of these genes was correlated to age but not to hearing
loss. Note that Tanaka et al. grouped their data for multiple sound
frequencies, whereas correlations were made with individual
sound frequencies in the present study. Many of the genes that
were correlated to both age and hearing loss have cytoprotective
functions or have both survival and apoptotic function (Scd1,
Cygb, Duo2, Aass, Slc38a5, Nqo1, Vim, and Dhcr24). In terms of
similarities, Tanaka et al. reported changes in the Txnip gene, and
we observed the down-regulation of a related gene: thioredoxin
reductase 1 (Txnrd1). Note that Tanaka et al. did not find a
correlation between the expression of Gpx6 and the degree of
hearing loss, but both studies confirm the importance of this gene
that is upregulated with age in both the mouse and rat cochlea,
presumably to help preserve hearing in old age. The differences in
findings for other genes may relate to the different species
employed, the type of microarray utilized, or differences in the
analysis of the microarray and qPCR results carried out in both
studies. Lastly, notice also that the individual effects of age and of
hearing loss in the expression patterns could not be clearly
addressed in Tanaka et al.’s study, and this issue will be interesting
to address in subsequent investigations.
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Table 3. Correlation between Txnrd1 gene expression and audiological measurements.
Sig. Log Ratio (GeneChip) Fold Change (GeneChip) Fold Change (qPCR)
ABR 3 kHz p =0.083, r2 = 0.0768, F = 3.161 p= 0.077, r2 = 0.079, F = 3.304 p= 0.516, r2 = 0.011, F = 0.429
ABR 6 kHz P= **0.004, r2 = 0.195, F = 9.189 p= **0.006, r2 = 0.180, F = 8.339 p= 0.561, r2 = 0.009, F = 0.345
ABR 12 kHz p = ***0.0003, r2 = 0.293, F = 15.75 p = ***0.0009, r2 = 0.255, F = 13.00 p = 0.833, r2 = 0.0012, F = 0.045
ABR 24 kHz p = **0.002, r2 = 0.222, F = 10.87 p = **0.006, r2 = 0.181, F = 8.395 p= 0.849, r2 = 0.0009, 0.037
ABR 32 kHz p = **0.0066, r2 = 0.179, F = 8.272 p= **0.0079, r2 = 0.172, F = 7.875 p= 0.746, r2 = 0.0028, F = 0.107
ABR 48 kHz p = ***0.0006, r2 = 0.269, F = 13.96 p = **0.0012, r2 = 0.245, F = 12.36 p = 0.909, r2 = 0.0003, F = 0.013
DPOAE Low Freq. p = **0.005, r2 = 0.188, F = 8.822 p= **0.0065, r2 = 0.179, F = 8.283 p= 0.355, r2 = 0.0226, F = 0.877
DPOAE Mid Freq. p = **0.008, r2 = 0.171, F = 7.818 p= **0.004, r2 = 0.195, F = 9.213 p= 0.478, r2 = 0.013, F = 0.515
DPOAE High Freq. p = *0.034, r2 = 0.113, F = 4.823 p= **0.0075, r2 = 0.174, F = 7.981 p= 0.598, r2 = 0.007, F = 0.282
* denotes statistical significance at 0.05 level;
** at the 0.01 level;
*** at the 0.001 level.
doi:10.1371/journal.pone.0090279.t003
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